Skip to main content

Advertisement

Log in

Challenges to Treatment of Chronic Pain and Addiction During the “Opioid Crisis”

  • Invited Commentary
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Health care in the USA faces a double challenge, the crisis of chronic pain and the crisis of opioid misuse and overdose. Patients have been prescribed opioids at high doses with unclear indications for long periods of time, putting them at high risk for morbidity and mortality. A significant proportion of these patients have comorbid psychiatric or substance use disorders complicating their pain conditions. The challenges to treating these patients adequately are discussed, along with potential solutions to these issues at the level of the individual provider, healthcare systems, and society.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Daubresse M, Chang H-Y, Yu Y, et al. Ambulatory diagnosis and treatment of non-malignant pain in the United States, 2000–2010. Medical care. 2013;51(10).

  2. Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Ann Rev Public Health. 2015;36:559–74.

    Article  Google Scholar 

  3. Center for Disease Control. CDC’s top ten: 5 health achievements in 2013 and 5 health threats in 2014. Atlanta, GA: CDC. http://blogs.cdc.gov/cdcworksforyou24-7/2013/12/cdc%E2. 2014;80.

  4. Franklin G, Sabel J, Jones CM, et al. A comprehensive approach to address the prescription opioid epidemic in Washington State: milestones and lessons learned. Am J Public Health. 2015;105(3):463–9.

    Article  PubMed  Google Scholar 

  5. Martin BC, Fan MY, Edlund MJ, Devries A, Braden JB, Sullivan MD. Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med. 2011;26(12):1450–7.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Goesling J, Henry MJ, Moser SE, et al. Symptoms of depression are associated with opioid use regardless of pain severity and physical functioning among treatment-seeking patients with chronic pain. J Pain. 2015;16(9):844–51.

    Article  PubMed  Google Scholar 

  7. Upadhyay J, Maleki N, Potter J, et al. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain: J Neurol. 2010;133(7):2098–114.

    Article  Google Scholar 

  8. Younger JW, Chu LF, D’Arcy NT, Trott KE, Jastrzab LE, Mackey SC. Prescription opioid analgesics rapidly change the human brain. Pain. 2011;152(8):1803–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Scherrer JF, David Schneider F, Lustman PJ. Opioid analgesics and chronic non-cancer pain: a prescription for research in primary care. Fam Pract. 2016.

  10. Scherrer JF, Salas J, Copeland LA, et al. Response to Ruan et al. Letter to the editor: increased risk of depression recurrence after initiation of prescription opioids in noncancer pain patients. J Pain. 2016;17(8):946–7.

    Article  PubMed  Google Scholar 

  11. Scherrer JF, Salas J, Copeland LA, et al. Increased risk of depression recurrence after initiation of prescription opioids in noncancer pain patients. J Pain. 2016;17(4):473–82.

    Article  PubMed  Google Scholar 

  12. Scherrer JF, Salas J, Sullivan MD, et al. The influence of prescription opioid use duration and dose on development of treatment resistant depression. Prev Med. 2016;91:110–6.

    Article  PubMed  Google Scholar 

  13. Franklin GM, Fulton-Kehoe D, Turner JA, Sullivan MD, Wickizer TM. Changes in opioid prescribing for chronic pain in Washington State. J Am Board Fam Med. 2013;26(4):394–400.

    Article  PubMed  Google Scholar 

  14. Robinson PJ, Reiter JT. Prescription drug abuse in primary care. Behavioral Consultation and Primary Care: Springer; 2016:269–286.

  15. Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med. 2007;8(7):573–84.

    Article  PubMed  Google Scholar 

  16. Cicero TJ, Ellis MS, Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 2015;373(18):1789–90.

    Article  PubMed  Google Scholar 

  17. Peavy KM, Banta-Green CJ, Kingston S, Hanrahan M, Merrill JO, Coffin PO. “Hooked on” prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients. J Psychoactive Drugs. 2012;44(3):259–65.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel Krashin.

Ethics declarations

Conflict of Interest

Daniel Krashin, Natalia Murinova, and Mark Sullivan declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krashin, D., Murinova, N. & Sullivan, M. Challenges to Treatment of Chronic Pain and Addiction During the “Opioid Crisis”. Curr Pain Headache Rep 20, 65 (2016). https://doi.org/10.1007/s11916-016-0596-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-016-0596-2

Keywords

Navigation